We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Investors and businesses may be legally required to tell the government about certain sensitive acquisitions under the National Security and Investment Act.
You must include the appropriate legal basis for your application when you apply to MHRA for a marketing authorisation.
This guide provides information on statutory derecognition of a trade union
How to use a randomised controlled trial to evaluate your digital health product.
How to use a quasi-experimental study to evaluate your digital health product.
Information on enhancing communications resilience and how we work with telecommunication service providers to manage the risk of disruption to public networks.
Information on trade sanctions, arms embargoes and trade restrictions, including trade controls, transit controls and restrictions on terrorist organisations.
How to create a model of how your digital health product works and choose measures for your evaluation.
The rules on working hours - hour and limits, rests, health assessments and terms and conditions
Minimum wage rates for different types of paid employment - time work, output work, unmeasured work, salaried hours work.
Lists of standards that businesses can use to show their products, services or processes comply with essential requirements of legislation.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Submissions related to human medicines need to be submitted directly to the MHRA.
This Directorate Children and Young People (DCYP) COVID-19 page provides important advice and updates for service parents.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
How the Thames Barrier works, and when it is scheduled to close.
Actions that trial sponsors should consider to build resilience into clinical trial design
Check how quickly you’ll receive a decision on your UK visa application if you are applying from outside the UK.
What you need to do to place a medical device on the Great Britain, Northern Ireland and European Union (EU) markets.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.